A Phase 1b Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies
Phase of Trial: Phase I
Latest Information Update: 27 Nov 2019
Price : $35 *
At a glance
- Drugs Epacadostat (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics
- 14 Mar 2019 Planned initiation date(estimated date for recruitment of the first subject) changed from 1 February 2019 to 1 April 2019.
- 28 Jan 2019 Status changed from not yet recruiting to recruiting.
- 14 Jan 2019 Planned initiation date changed from 1 Dec 2018 to 1 Jan 2019.